Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy

Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer

“…QLQ-PR25 functional and symptom raw scores were linearly transformed to a 0–100 scale according to the EORTC scoring manuals. A change of 10 % or more from baseline was defined as a clinically meaningful difference in symptoms (Patient Reported Outcome Measures, PROM 10% ) [30] , [31] .…”